Yingchang Mi

11PUBLICATIONS
27CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 28, 2025
Venetoclax combined with homoharringtonine, cytarabine and aclacinomycin as induction therapy in newly diagnosed Chinese acute myeloid leukaemia patients: A multicentre phase II study.

Yaxian Tan, Xingli Zhao, Xiaohui Suo

|Jun 30, 2025
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong, Wenbing Liu, Yuntao Liu

|May 19, 2025
Comprehensive omics-based classification system in adult patients with B-cell acute lymphoblastic leukemia.

Yang Song, Ting Liu, Qishan Hao

|Feb 10, 2025
Classification of acute myeloid leukemia based on multi-omics and prognosis prediction value.

Yang Song, Zhe Wang, Guangji Zhang

|Aug 07, 2023
A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects.

Zhe Wang, Ting Liu, Wenbing Liu

|Mar 06, 2023
A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms.

Qiujin Shen, Yahui Feng, Xiaowen Gong

Pageof 2

Frequent Collaborators

8 joint publications

Jianxiang Wang

6 joint publications

Kaiqi Liu

3 joint publications

Yang Song

3 joint publications

Hui Wei